glp 1 receptor agonists beyond their pancreatic effects Risk of cancer associated with GLP-1 agonist therapy Localized GLP1 receptor pre-internalization directs
Description
Lancet 368, 16961705
PMID: 18541709
Investigation 79 (2), 616619
They block the normal reward processing, so if the pathway has been hijacked by substances, it may be rewired once again to restore normal functioning
Oral formulations are anticipated to gain faster acceptance among patients seeking non-injectable options for long-term therapy use
You can book a 15-minute free consult right here or subscribe to my blog to get future updates on how to work with your body instead of against it.
